CH624124A5 - - Google Patents

Download PDF

Info

Publication number
CH624124A5
CH624124A5 CH769177A CH769177A CH624124A5 CH 624124 A5 CH624124 A5 CH 624124A5 CH 769177 A CH769177 A CH 769177A CH 769177 A CH769177 A CH 769177A CH 624124 A5 CH624124 A5 CH 624124A5
Authority
CH
Switzerland
Prior art keywords
isoglutamine
alanyl
acid
benzyl
group
Prior art date
Application number
CH769177A
Other languages
English (en)
French (fr)
Inventor
Yuichi Yamamura
Tetsuo Shiba
Ichiro Azuma
Shoichi Kusumoto
Tadamasa Hirayama
Tsuneo Kusama
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP7407276A external-priority patent/JPS5914038B2/ja
Priority claimed from JP51150328A external-priority patent/JPS6033119B2/ja
Priority claimed from JP1112277A external-priority patent/JPS5398922A/ja
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of CH624124A5 publication Critical patent/CH624124A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH769177A 1976-06-23 1977-06-23 CH624124A5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7407276A JPS5914038B2 (ja) 1976-06-23 1976-06-23 新規ムラミルジペプチド誘導体
JP51150328A JPS6033119B2 (ja) 1976-12-16 1976-12-16 新規ムラミルジペプチド誘導体
JP1112277A JPS5398922A (en) 1977-02-03 1977-02-03 Novel melamyldipeptide derivative

Publications (1)

Publication Number Publication Date
CH624124A5 true CH624124A5 (pl) 1981-07-15

Family

ID=27279285

Family Applications (1)

Application Number Title Priority Date Filing Date
CH769177A CH624124A5 (pl) 1976-06-23 1977-06-23

Country Status (9)

Country Link
US (1) US4101536A (pl)
CA (1) CA1105005A (pl)
CH (1) CH624124A5 (pl)
DE (1) DE2728324A1 (pl)
FR (1) FR2375249A1 (pl)
GB (1) GB1563561A (pl)
NL (1) NL171063C (pl)
SE (1) SE446740B (pl)
SU (1) SU793384A3 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU727647A1 (ru) * 1977-11-02 1980-04-15 Институт биоорганической химии им.М.М.Шемякина Гликопептиды,обладающие противоопухолевой активностью и способ их получени
US4397844A (en) * 1978-02-24 1983-08-09 Ciba-Geigy Corporation Antigen derivatives and processes for their preparation
JPS5543030A (en) * 1978-09-21 1980-03-26 Dai Ichi Seiyaku Co Ltd Prophylactic and remedy for microbial infection disease
US4335111A (en) * 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds
FR2449697A1 (fr) 1979-02-20 1980-09-19 Anvar Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant
JPS55111499A (en) * 1979-02-21 1980-08-28 Takeda Chem Ind Ltd Glucosamine derivative and its preparation
US4391800A (en) * 1979-04-27 1983-07-05 Merck & Co., Inc. Immunologically active peptidyl disaccharides and methods of preparation
FI75578C (fi) * 1979-07-25 1988-07-11 Ciba Geigy Ag Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
US4406889A (en) * 1980-02-15 1983-09-27 Ciba-Geigy Corporation Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use
US4340588A (en) * 1980-03-28 1982-07-20 Research Corporation Brucellosis vaccine for cattle containing mycolate esters of trehalose
US4310514A (en) * 1980-05-05 1982-01-12 Merck & Co., Inc. Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation
US4315913A (en) * 1980-06-09 1982-02-16 Merck & Co. Inc. Immunologically active dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives and methods of preparation
GR78246B (pl) * 1981-01-23 1984-09-26 Ciba Geigy Ag
JPS5920297A (ja) * 1982-07-27 1984-02-01 Dai Ichi Seiyaku Co Ltd ムラミルジペプチド誘導体
US4772466A (en) * 1983-08-22 1988-09-20 Syntex (U.S.A.) Inc. Vaccines comprising polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4770874A (en) * 1983-08-22 1988-09-13 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) * 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
DK585886A (da) * 1985-12-24 1987-06-25 Takeda Chemical Industries Ltd Immunstimulerende middel og anvendelse deraf
US5554372A (en) * 1986-09-22 1996-09-10 Emory University Methods and vaccines comprising surface-active copolymers
US4895835A (en) * 1987-11-20 1990-01-23 Nisshin Oil Mills, Ltd. Muramyl peptide derivatives and use thereof
US5149529A (en) * 1988-04-08 1992-09-22 Board Of Trustees Of Leland Chiron Corporation Compositions and treatment for herpes simplex
US4950645A (en) * 1988-07-08 1990-08-21 Immunotherapeutics, Inc. Composition for macrophage activation
US5416070A (en) * 1988-07-08 1995-05-16 Immunotherapeutics, Inc. Composition for macrophage activation
DE3840538A1 (de) * 1988-12-01 1990-06-07 Helopharm Petrik Co Kg Peptidoglucan-dimere, verfahren zu ihrer herstellung und ihre verwendung als immunmodulatoren
GB9320820D0 (en) * 1993-10-08 1993-12-01 Biokine Tech Ltd Compounds for medicinal use
US6156319A (en) * 1994-07-25 2000-12-05 The Trustees Of The University Of Pennsylvania Soluble herpesvirus glycoprotein complex vaccine
US6649746B1 (en) 1999-05-07 2003-11-18 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
EP1670508B1 (en) 2003-02-28 2012-10-24 Trustees Of The University Of Pennsylvania Compositions, methods and kits relating to poxvirus subunit vaccines
JP2008522951A (ja) * 2004-07-19 2008-07-03 ベイラー・カレツジ・オブ・メデイシン サイトカインシグナル伝達調節物質の調節および免疫療法のための応用
ES2380481T3 (es) * 2005-06-08 2012-05-14 Yisheng Biopharma (Singapore) Pte. Ltd. Sustancias inmunogénicas que comprenden un adyuvante a base de ácido poliinosínico y ácido policitidílico
US7868159B2 (en) * 2005-06-23 2011-01-11 Baylor College Of Medicine Modulation of negative immune regulators and applications for immunotherapy
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
CN101678082B (zh) 2007-03-26 2013-06-19 再生医药有限公司 使用cxcl9和抗cxcl9抗体促进骨髓保护和再生的方法
US8324369B2 (en) * 2007-11-30 2012-12-04 Baylor College Of Medicine Dendritic cell vaccine compositions and uses of same
US9808504B2 (en) 2009-09-22 2017-11-07 Yale University Immunogenic epitopes as targets for universal cancer vaccines
KR101955365B1 (ko) 2011-07-12 2019-03-07 필라델피아 헬스 앤드 에듀케이션 코포레이션 디/비/에이 드렉셀 유니버시티 컬리지 오브 메디슨 신규한 클로스트리듐 디피실(Clostridium Difficile) DNA 백신
WO2015116178A1 (en) 2014-01-31 2015-08-06 Thomas Jefferson University Fusion proteins for modulating regulatory and effector t cells
US9834610B2 (en) 2013-01-31 2017-12-05 Thomas Jefferson University Fusion proteins for modulating regulatory and effector T cells
WO2016138286A1 (en) 2015-02-26 2016-09-01 Stc.Unm Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
WO2020140007A1 (en) 2018-12-28 2020-07-02 University Of Rochester Gene therapy for best1 dominant mutations

Also Published As

Publication number Publication date
SU793384A3 (ru) 1980-12-30
DE2728324A1 (de) 1978-01-12
SE7707276L (sv) 1978-02-10
NL7706948A (nl) 1977-12-28
GB1563561A (en) 1980-03-26
DE2728324C2 (pl) 1988-07-07
NL171063B (nl) 1982-09-01
CA1105005A (en) 1981-07-14
NL171063C (nl) 1983-02-01
FR2375249B1 (pl) 1980-04-11
FR2375249A1 (fr) 1978-07-21
SE446740B (sv) 1986-10-06
US4101536A (en) 1978-07-18

Similar Documents

Publication Publication Date Title
CH624124A5 (pl)
EP0310519A1 (fr) Nouveaux esters d'acide androstane 17-carboxylique, procédé pour leur préparation et médicament les contenant
CA1251000A (fr) Dipeptides, leur preparation et les medicaments qui les contiennent
CA1335686C (fr) Vinblastine et composition pharmaceutique les contenant
LU86491A1 (fr) Nouveaux disaccharides,leur preparatione et leur utilisation comme medicaments
EP0241541A1 (en) Novel derivatives of the oligosaccharide antibiotic complex 13-384, their preparation and pharmaceutical compositions containing them
EP0284461B1 (fr) Nouveaux dérivés de l'acide glutamique, leurs sels, procédé de préparation, application à titre de médicaments et compositions les renfermant
FR2460289A1 (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2605321A1 (fr) Anthracycline glycosides a activite antitumorale, leur preparation, les composes intermediaires de cette preparation et compositions et utilisation de ces substances.
CA2408453A1 (fr) Derives de l'uridine comme antibiotiques
US4560703A (en) Clavulone derivatives, process for preparing the same, and use of said compounds
EP0315519B1 (fr) Nouveaux dérivés de l'acide aminopimélique, leur procédé de préparation et leur application comme médicaments
EP0772630B1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
EP0215687B1 (fr) Substance biologiquement active, appelée girolline, extraité de l'éponge Pseudaxinyssa cantharella, son procédé de préparation et les compositions pharmaceutiques qui la contiennent
EP0143675B1 (fr) Nouveaux dérivés de nitrosourée, leur procédé de préparation et compositions pharmaceutiques les contenant
JP3108474B2 (ja) 活性型ビタミンｄ誘導体
FR2468582A1 (fr) Antibiotiques de type macrolide, leur procede de preparation et compositions therapeutiques les contenant
FR2510577A1 (fr) Composes organiques azotes extraits de plantes et leurs derives, leur preparation et leurs utilisations therapeutiques, notamment en tant qu'agents antineoplastiques
JPS6312879B2 (pl)
BE887456R (fr) Procede de production de composes intermediaires pour l'obtention de la spectinomycine et de ses analogues et produits de ce procede
JP2710052B2 (ja) コードファクター関連化合物及びその製造法並びに該化合物を含有する免疫増強剤
JPS6225680B2 (pl)
EP0054025A1 (fr) Nouveaux derives de l'alpha, alpha'-trehalose et medicaments les contenant
Kurihara et al. Chemistry of Benzeneglycols Part XVIII. Synthesis of (-)-N-Methyl-2-deoxystreptamine and Its Absolute Configuration
FR2476652A1 (fr) Derives 3', 4'-anhydro-4'-epi de la kanamycine a et leur procede de preparation

Legal Events

Date Code Title Description
PL Patent ceased